ClearPoint Neuro Inc
CLPT
NSC
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
15.77
USD
-0.25
(-1.56%)
Optionable: Yes Market Cap: 386 M 90-day average vol: 198,351
Previous close: 16.02 Open: 15.94 Bid: 17.22 Ask: 17.22
52 week range
7.00 20.55
Last updated: Wednesday 17th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 20.23 |
Price per Book TTM ($) | 9.16 |
PE Ratio (TTM) | -22.30 |
Book Value per Share ($) | 1.93 |
5 Year PE Range-34.3 |
Returns
7 Day Return | 8.61% | |
1 Month Return | 27.07% | |
3 Month Return | 81.06% | |
1 Year Return | -11.85% | |
3 Year Return | 367.95% | |
5 Year Return | 717.10% | |
YTD Return | 40.55% |
Risk
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 59.19 |
14 Day SMA ($) | 15.37 |
14 Day EMA ($) | 15.34 |
Money Flow Index | 61.30 |
Average True Range | 1.04 |
50 Day SMA ($) | 13.24 |
200 Day SMA ($) | 11.33 |
ADX | 16.50 |
MACD | 0.83 |
Growth
Free Cash Flow QoQ Growth | 24.07% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | -10.53% |
Revenue QoQ Growth | 17.49% |
EPS YoY Growth | 0.00% |
Profitability
Chart
News
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2021 Results
Yahoo Finance 3/1/2022
ClearPoint Neuro Q4 2021 Earnings Preview
Seeking Alpha 2/28/2022
ClearPoint Neuro estimates Q4 prelim revenue in-line with consensus
Seeking Alpha 2/15/2022
ClearPoint Neuro Reports Fourth Quarter and Full Year 2021 Preliminary Revenue Results and Guidance for Full Year 2022 Revenue
Yahoo Finance 2/15/2022
ClearPoint Neuro: Underlying Growth Potential Concealed By COVID
Seeking Alpha 1/14/2022
Adirondack Trust Co Buys Vanguard Russell 2000 Index Fund, Ford Motor Co, Arco Platform, Sells ...
Yahoo Finance 1/13/2022
ClearPoint Neuro to Participate at the H.C. Wainwright BIOCONNECT Virtual Conference
Yahoo Finance 1/5/2022
Royce Value Trust, Inc. Buys Calix Inc, MaxCyte Inc, Dutch Bros Inc, Sells EQT Corp, ...
Yahoo Finance 12/17/2021
ClearPoint Neuro (NASDAQ:CLPT) shareholders are still up 635% over 3 years despite pulling back 13% in the past week
Yahoo Finance 11/20/2021
ClearPoint Neuro Congratulates Blackrock Neurotech on Receiving Breakthrough Device Designation from the FDA for the MoveAgain Brain-Computer Interface System
Yahoo Finance 11/17/2021
ClearPoint Neuro, Inc. 2021 Q3 - Results - Earnings Call Presentation
Seeking Alpha 11/10/2021
ClearPoint Neuro, Inc. (CLPT) CEO Joseph Burnett on Q3 2021 Results - Earnings Call Transcript
Seeking Alpha 11/9/2021
ClearPoint Neuro EPS misses by $0.02, beats on revenue
Seeking Alpha 11/9/2021
ClearPoint Neuro Reports Third Quarter 2021 Results
Yahoo Finance 11/9/2021
ClearPoint Neuro Q3 2021 Earnings Preview
Seeking Alpha 11/8/2021
ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients
Yahoo Finance 11/8/2021
ClearPoint Neuro to Present at the 2021 Stifel Virtual Healthcare Conference
Yahoo Finance 11/4/2021
Internationally Renowned Neurosurgeon and Accomplished Researcher Dr. Linda M. Liau Joins ClearPoint Neuro Board of Directors
Yahoo Finance 11/2/2021
ClearPoint Neuro to Announce Third Quarter 2021 Results November 9, 2021
Yahoo Finance 10/26/2021
ClearPoint Neuro: Becoming The Neurosurgical Platform Of Choice
Seeking Alpha 10/1/2021
Is ClearPoint Neuro (NASDAQ:CLPT) Weighed On By Its Debt Load?
Yahoo Finance 9/21/2021
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 19.076
Financials
CLPT Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 5 M | 4 M | 4 M | 5 M | 6 M | 7 M | 7 M | 11 M | 13 M | 16 M |
| Cost of sales | -2 M | 851547 | 1 M | 1 M | 2 M | 2 M | 2 M | 4 M | 3 M | 5 M |
| Gross operating profit | 5 M | 3 M | 2 M | 3 M | 3 M | 4 M | 5 M | 7 M | 9 M | 11 M |
| Selling Gen & administrative expense | 6 M | 7 M | 8 M | 8 M | 8 M | 8 M | 8 M | 9 M | 11 M | 16 M |
| Research & development expense | 2 M | 3 M | 3 M | 2 M | 3 M | 3 M | 2 M | 3 M | 5 M | 9 M |
| Operating income | -3 M | -7 M | -10 M | -8 M | -7 M | -6 M | -5 M | -5 M | -6 M | -13 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | -167785 | 863792 | 6 M | 518167 | 470101 | 41410 | 64682 | 9000 | 882000 | -63000 |
| Pre-tax Income (EBT) | -6 M | -7 M | -5 M | -8 M | -8 M | -7 M | -6 M | -6 M | -7 M | -14 M |
| Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from total operations | -6 M | -7 M | -5 M | -8 M | -8 M | -7 M | -6 M | -6 M | -7 M | -14 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | -6 M | -7 M | -5 M | -8 M | -8 M | -7 M | -6 M | -6 M | -7 M | -14 M |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net income available for common | -6 M | -7 M | -5 M | -8 M | -8 M | -7 M | -6 M | -6 M | -7 M | -14 M |
| Depreciation | 2 M | 569601 | 708248 | 683092 | 580138 | 542812 | 109439 | 144000 | 334000 | 159000 |
| Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income before depreciation (EBITDA) | -3 M | -6 M | -3 M | -7 M | -7 M | -6 M | -5 M | -4 M | -5 M | -13 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | -5.6 | -4.8 | -3.2 | -4.4 | -2.93 | -0.93 | -0.56 | -0.42 | -0.43 | -0.69 |
| Diluted EPS total | -5.6 | -4.8 | -3.2 | -4.4 | -2.93 | -0.93 | -0.56 | -0.42 | -0.43 | -0.69 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!